Page last updated: 2024-12-06

4-chromanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Chromanone is a heterocyclic compound with a chromanone ring system. It is a valuable building block in organic synthesis, serving as a precursor for various biologically active compounds. Its derivatives have demonstrated diverse pharmacological activities, including anti-inflammatory, antioxidant, and anticancer properties. The compound has also been explored for its potential in treating neurological disorders. Research into 4-chromanone focuses on understanding its structure-activity relationships, developing new synthetic methods for its derivatives, and investigating its biological applications.'

Cross-References

ID SourceID
PubMed CID68110
CHEMBL ID453987
CHEBI ID180567
SCHEMBL ID28794
MeSH IDM0187361

Synonyms (49)

Synonym
AC-3079
2,3-dihydro-1-benzopyran-4-one
CHEBI:180567
2,3-dihydrochromen-4-one
chroman-4-one
isochromanone ,
nsc174058
4-chromanone ,
491-37-2
nsc-174058
chromanone
AB-131/40347218
einecs 207-736-3
1341-36-2
4h-1-benzopyran-4-one, 2,3-dihydro-
2,3-dihydro-4h-chromen-4-one
inchi=1/c9h8o2/c10-8-5-6-11-9-4-2-1-3-7(8)9/h1-4h,5-6h
4-chromanone, 97%
C1175
CHEMBL453987
STK801790
AKOS000120888
nsc 174058
BP-12827
FT-0618277
AM20040557
AB00814
dihydrochromone
2,3-dihydro-4h-1-benzopyran-4-one
3,4-dihydro-2h-benzopyran-4-one
2h-[1]benzopyran-4-one
4-chromanon
SCHEMBL28794
SY003783
mfcd00006840
DTXSID3060081
J-200067
3,4-dihydro-2h-1-benzopyran-4-one
STR01088
BS-3822
2,3-dihydro-4h-chromen-4-one #
2,3-dihydro-2-benzopyran-4-one
2,3-dihydro-4-benzopyranone
CS-W007464
F0001-1283
2h-chromen-4(3h)-one
BCP06538
EN300-18584
Z85920466
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
chromonesA chromenone that consists of a 1,4-benzopyrone skeleton and its substituted derivatives thereof.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID758733Cytotoxicity against human WM115 cells after 46 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones.
AID758732Cytotoxicity against human NALM6 cells after 46 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones.
AID355880Pesticidal activity against Dermatophagoides pteronyssinus after 24 hrs2003Journal of natural products, May, Volume: 66, Issue:5
Acaricidal activity of tonka bean extracts. Synthesis and structure-activity relationships of bioactive derivatives.
AID1186725Cytotoxicity against human HL60 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
AID1186726Cytotoxicity against human NALM6 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
AID758734Cytotoxicity against human HL60 cells after 46 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones.
AID1186727Cytotoxicity against human WM115 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (11.11)18.2507
2000's2 (11.11)29.6817
2010's9 (50.00)24.3611
2020's5 (27.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.95 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index42.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]